Scholarlink

<p>Antimicrobial Resistance (AMR) is a complex crisis of our time. Its evolution is not only driven by the microbes adapting to medicines designed to kill them, and by behavioural and structural drivers, but is also deeply entrenched in the historical inequities in the global health system. This article explores how concurrent crises, comprising armed conflict, climate change, and rising economic inequalities are actively accelerating resistance by eroding public health buffers and straining already fragmented health systems. It further examines the impact of a shrinking pie of global health funding and mounting national debt, which forces low-and middle-income countries to navigate impossible choices between competing priorities. As we navigate through this landscape it is important that we address AMR in a strategic manner, by adopting a ‘better care’ model and a ‘hot spot’ approach. To ensure this, any effective response should include civil society organizations, who can act as watchdogs to bring accountability to the global AMR response and ensure that global health delivery is inclusive of the most vulnerable populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Silent Evolution in Global Healthcare Crisis: Transcending the Clinical Realm to Address Antimicrobial Resistance

  • 期刊论文

  • 发表日期：

    2026年5月5日

查看全文
  • Sherin Susan Paul,
  • Satya Sivaraman,
  • Tracie Muraya,
  • Kerstin Åkerfeldt,
  • Anna Karin Sjöblom,
  • Mirfin Mpundu

摘要

Antimicrobial Resistance (AMR) is a complex crisis of our time. Its evolution is not only driven by the microbes adapting to medicines designed to kill them, and by behavioural and structural drivers, but is also deeply entrenched in the historical inequities in the global health system. This article explores how concurrent crises, comprising armed conflict, climate change, and rising economic inequalities are actively accelerating resistance by eroding public health buffers and straining already fragmented health systems. It further examines the impact of a shrinking pie of global health funding and mounting national debt, which forces low-and middle-income countries to navigate impossible choices between competing priorities. As we navigate through this landscape it is important that we address AMR in a strategic manner, by adopting a ‘better care’ model and a ‘hot spot’ approach. To ensure this, any effective response should include civil society organizations, who can act as watchdogs to bring accountability to the global AMR response and ensure that global health delivery is inclusive of the most vulnerable populations.